Sfoglia per Rivista
Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis
2007 BARTOLOZZI B; A. BOSI; ORSI C
Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients
2001 BIJKER N.; RUTGERS E.J; DUCHATEAU L.; PETERSE J.L; JULIEN J.P.; L. CATALIOTTI
CLINICAL DIAGNOSIS AND THERAPY OF CUTANEOUS MELANOMA IN SITU
1996 D. MASSI
Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma.
2005 RIGACCI L; CARRAI V; NASSI L; ALTERINI R; LONGO G; BERNARDI F; A. BOSI
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive bresat cancer:the preoperative "Arimidex" compared to Tamoxifen (PROACT) trial.
2006 L. CATALIOTTI; BUZDAR AU; NOGUCHI S; BINES J; TAKATSUKA Y; PETRAKOVA K; DUBE P; TOSELLO DE OLIVEIRA C
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens
2015 Thompson, Philip A; O'Brien, Susan M.; Wierda, William G.; Ferrajoli, Alessandra; Stingo, Francesco; Smith, Susan C.; Burger, Jan A.; Estrov, Zeev; Jain, Nitin; Kantarjian, Hagop M.; Keating, Michael J.
Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: novel criteria of assesment and correlations with constitutional adenomatous polyposis coli gene mutations.
1996 R. VALANZANO; CAMA A.; VOLPE R.; CURIA MC.; MENCUCCI R.
Consensus Conference on the treatment of in situ ductal carcinoma of the breast April 22-25 1999
2000 SCHWARTZ G.F.; SOLIN L.J.; OLIVOTTO I.A.; THE CONSENSUS CONFERENCE COMMITTEE; L. CATALIOTTI
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes.
2011 L.R. Silverman ; P.Fenaux ; G.J.Mufti ; V.Santini ; E.Hellström-Lindberg ; N.Gattermann ; G. Sanz ; A.F. List ; S.D.Gore ; J.F. Seymour
Cytopathological diagnosis in a cancer registry: a useful diagnostic tool?
2007 Caldarella A.; Crocetti E.; Taddei G.L.; Paci E.
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP.
2003 M. SANTUCCI; N. PIMPINELLI; D. MASSI; M.E. KADIN; C.J.L.M. MEIJER; H.K. MULLER-HERMELINK; M. PAULLI; J. WECHSLER; R. WILLEMZE; H. AUDRING; M.G. BERNENGO; L. CERRONI.
Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase.
2009 Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V. Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V.
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR
1996 D. MASSI; T. SUSINI; L. SAVINO; V. BODDI; G. AMUNNI; M. COLAFRANCESCHI.
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck
2002 A. FRANCHI; M. SANTUCCI; E. MASINI; I. SARDI; M. PAGLIERANI; O. GALLO
Gastric cancer in a high-risk area in Italy: Histopathologic patterns according to Lauren's classification
1988 Amorosi; A.; Bianchi; S.; Buiatti; E.; Cipriani; F.; Palli; D.; Zampi; G.
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
2005 Marchi E;Alinari L;Tani M;Stefoni V;Pimpinelli N;Berti E;Pagano L;Bernengo MG;Zaja F;Rupoli S;Pileri S;Baccarani M;Zinzani PL
Gender differences in non-small cell lung cancer: a population-based study
2007 CALDARELLA A; CROCETTI E; C. COMIN; JANNI A; PEGNA AL; PACI E
Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy
2010 A.Deganello; A.Franchi; I.Sardi; L.Pignataro; CR. Leemans; O.Gallo
Homoharringtonine: history, current research, and future direction.
2001 KANTARJIAN HM; TALPAZ M; V. SANTINI; MURGO A; CHESON B; O'BRIEN SM.
Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.
2005 G. CSERNI; S. BIANCHI; W. BOECKER ET AL
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis | 2007 | BARTOLOZZI B; A. BOSI; ORSI C | |
Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients | 2001 | BIJKER N.; RUTGERS E.J; DUCHATEAU L.; PETERSE J.L; JULIEN J.P.; L. CATALIOTTI | |
CLINICAL DIAGNOSIS AND THERAPY OF CUTANEOUS MELANOMA IN SITU | 1996 | D. MASSI | |
Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma. | 2005 | RIGACCI L; CARRAI V; NASSI L; ALTERINI R; LONGO G; BERNARDI F; A. BOSI | |
Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive bresat cancer:the preoperative "Arimidex" compared to Tamoxifen (PROACT) trial. | 2006 | L. CATALIOTTI; BUZDAR AU; NOGUCHI S; BINES J; TAKATSUKA Y; PETRAKOVA K; DUBE P; TOSELLO DE OLIVEIRA C | |
Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens | 2015 | Thompson, Philip A; O'Brien, Susan M.; Wierda, William G.; Ferrajoli, Alessandra; Stingo, Francesco; Smith, Susan C.; Burger, Jan A.; Estrov, Zeev; Jain, Nitin; Kantarjian, Hagop M.; Keating, Michael J. | |
Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis: novel criteria of assesment and correlations with constitutional adenomatous polyposis coli gene mutations. | 1996 | R. VALANZANO; CAMA A.; VOLPE R.; CURIA MC.; MENCUCCI R. | |
Consensus Conference on the treatment of in situ ductal carcinoma of the breast April 22-25 1999 | 2000 | SCHWARTZ G.F.; SOLIN L.J.; OLIVOTTO I.A.; THE CONSENSUS CONFERENCE COMMITTEE; L. CATALIOTTI | |
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes. | 2011 | L.R. Silverman ; P.Fenaux ; G.J.Mufti ; V.Santini ; E.Hellström-Lindberg ; N.Gattermann ; G. Sanz ; A.F. List ; S.D.Gore ; J.F. Seymour | |
Cytopathological diagnosis in a cancer registry: a useful diagnostic tool? | 2007 | Caldarella A.; Crocetti E.; Taddei G.L.; Paci E. | |
CYTOTOXIC/NATURAL KILLER CELL CUTANEOUS LYMPHOMAS: REPORT OF THE E.O.R.T.C. CUTANEOUS LYMPHOMA TASK FORCE WORKSHOP. | 2003 | M. SANTUCCI; N. PIMPINELLI; D. MASSI; M.E. KADIN; C.J.L.M. MEIJER; H.K. MULLER-HERMELINK; M. PAULLI; J. WECHSLER; R. WILLEMZE; H. AUDRING; M.G. BERNENGO; L. CERRONI. | |
Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase. | 2009 | Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V. Kantarjian HM; Larson RA; Guilhot F; O'Brien SG; Mone M; Rudoltz M; Krahnke T; Cortes J; Druker BJ; International Randomized Study of Interferon and STI571 (IRIS) Investigators. Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagi A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence-Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Blaise D; Maloisel F; Michallet M; Andreesen R; Nerl C; Freund M; Gattermann N; Ehninger G; Deininger M; Ottmann O; Peschel C; Fruehauf S; Neubauer A; le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; Rizzoli V; Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde-Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Robinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Santini V. | |
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR | 1996 | D. MASSI; T. SUSINI; L. SAVINO; V. BODDI; G. AMUNNI; M. COLAFRANCESCHI. | |
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck | 2002 | A. FRANCHI; M. SANTUCCI; E. MASINI; I. SARDI; M. PAGLIERANI; O. GALLO | |
Gastric cancer in a high-risk area in Italy: Histopathologic patterns according to Lauren's classification | 1988 | Amorosi; A.; Bianchi; S.; Buiatti; E.; Cipriani; F.; Palli; D.; Zampi; G. | |
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. | 2005 | Marchi E;Alinari L;Tani M;Stefoni V;Pimpinelli N;Berti E;Pagano L;Bernengo MG;Zaja F;Rupoli S;Pileri S;Baccarani M;Zinzani PL | |
Gender differences in non-small cell lung cancer: a population-based study | 2007 | CALDARELLA A; CROCETTI E; C. COMIN; JANNI A; PEGNA AL; PACI E | |
Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy | 2010 | A.Deganello; A.Franchi; I.Sardi; L.Pignataro; CR. Leemans; O.Gallo | |
Homoharringtonine: history, current research, and future direction. | 2001 | KANTARJIAN HM; TALPAZ M; V. SANTINI; MURGO A; CHESON B; O'BRIEN SM. | |
Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. | 2005 | G. CSERNI; S. BIANCHI; W. BOECKER ET AL |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile